198 related articles for article (PubMed ID: 22039883)
1. Targeting a DNA binding motif of the EVI1 protein by a pyrrole-imidazole polyamide.
Zhang Y; Sicot G; Cui X; Vogel M; Wuertzer CA; Lezon-Geyda K; Wheeler J; Harki DA; Muzikar KA; Stolper DA; Dervan PB; Perkins AS
Biochemistry; 2011 Dec; 50(48):10431-41. PubMed ID: 22039883
[TBL] [Abstract][Full Text] [Related]
2. Targeted suppression of EVI1 oncogene expression by sequence-specific pyrrole-imidazole polyamide.
Syed J; Pandian GN; Sato S; Taniguchi J; Chandran A; Hashiya K; Bando T; Sugiyama H
Chem Biol; 2014 Oct; 21(10):1370-1380. PubMed ID: 25219965
[TBL] [Abstract][Full Text] [Related]
3. Identification of binding sites of EVI1 in mammalian cells.
Yatsula B; Lin S; Read AJ; Poholek A; Yates K; Yue D; Hui P; Perkins AS
J Biol Chem; 2005 Sep; 280(35):30712-22. PubMed ID: 16006653
[TBL] [Abstract][Full Text] [Related]
4. Repression of RUNX1 activity by EVI1: a new role of EVI1 in leukemogenesis.
Senyuk V; Sinha KK; Li D; Rinaldi CR; Yanamandra S; Nucifora G
Cancer Res; 2007 Jun; 67(12):5658-66. PubMed ID: 17575132
[TBL] [Abstract][Full Text] [Related]
5. Zinc fingers 1-7 of EVI1 fail to bind to the GATA motif by itself but require the core site GACAAGATA for binding.
Perkins AS; Kim JH
J Biol Chem; 1996 Jan; 271(2):1104-10. PubMed ID: 8557637
[TBL] [Abstract][Full Text] [Related]
6. Suppression of GPR56 expression by pyrrole-imidazole polyamide represents a novel therapeutic drug for AML with high EVI1 expression.
Saha HR; Kaneda-Nakashima K; Shimosaki S; Suekane A; Sarkar B; Saito Y; Ogoh H; Nakahata S; Inoue K; Watanabe T; Nagase H; Morishita K
Sci Rep; 2018 Sep; 8(1):13741. PubMed ID: 30214063
[TBL] [Abstract][Full Text] [Related]
7. A novel gene silencer, pyrrole-imidazole polyamide targeting human lectin-like oxidized low-density lipoprotein receptor-1 gene improves endothelial cell function.
Ueno T; Fukuda N; Tsunemi A; Yao EH; Matsuda H; Tahira K; Matsumoto T; Matsumoto K; Matsumoto Y; Nagase H; Sugiyama H; Sawamura T
J Hypertens; 2009 Mar; 27(3):508-16. PubMed ID: 19330905
[TBL] [Abstract][Full Text] [Related]
8. Anti-repression of RNA polymerase II transcription by pyrrole-imidazole polyamides.
Dickinson LA; Trauger JW; Baird EE; Ghazal P; Dervan PB; Gottesfeld JM
Biochemistry; 1999 Aug; 38(33):10801-7. PubMed ID: 10451376
[TBL] [Abstract][Full Text] [Related]
9. Intergenic splicing of MDS1 and EVI1 occurs in normal tissues as well as in myeloid leukemia and produces a new member of the PR domain family.
Fears S; Mathieu C; Zeleznik-Le N; Huang S; Rowley JD; Nucifora G
Proc Natl Acad Sci U S A; 1996 Feb; 93(4):1642-7. PubMed ID: 8643684
[TBL] [Abstract][Full Text] [Related]
10. Rearrangement of the AML1/CBFA2 gene in myeloid leukemia with the 3;21 translocation: expression of co-existing multiple chimeric genes with similar functions as transcriptional repressors, but with opposite tumorigenic properties.
Zent C; Kim N; Hiebert S; Zhang DE; Tenen DG; Rowley JD; Nucifora G
Curr Top Microbiol Immunol; 1996; 211():243-52. PubMed ID: 8585955
[TBL] [Abstract][Full Text] [Related]
11. Gene expression changes in a tumor xenograft by a pyrrole-imidazole polyamide.
Raskatov JA; Nickols NG; Hargrove AE; Marinov GK; Wold B; Dervan PB
Proc Natl Acad Sci U S A; 2012 Oct; 109(40):16041-5. PubMed ID: 22988074
[TBL] [Abstract][Full Text] [Related]
12. Functional features of EVI1 and EVI1Δ324 isoforms of MECOM gene in genome-wide transcription regulation and oncogenicity.
Sayadi A; Jeyakani J; Seet SH; Wei CL; Bourque G; Bard FA; Jenkins NA; Copeland NG; Bard-Chapeau EA
Oncogene; 2016 May; 35(18):2311-21. PubMed ID: 26234679
[TBL] [Abstract][Full Text] [Related]
13. The EVI1 gene in myeloid leukemia.
Nucifora G
Leukemia; 1997 Dec; 11(12):2022-31. PubMed ID: 9447815
[TBL] [Abstract][Full Text] [Related]
14. The leukemia-associated gene MDS1/EVI1 is a new type of GATA-binding transactivator.
Soderholm J; Kobayashi H; Mathieu C; Rowley JD; Nucifora G
Leukemia; 1997 Mar; 11(3):352-8. PubMed ID: 9067573
[TBL] [Abstract][Full Text] [Related]
15. Sequence specific suppression of androgen receptor-DNA binding in vivo by a Py-Im polyamide.
Kurmis AA; Dervan PB
Nucleic Acids Res; 2019 May; 47(8):3828-3835. PubMed ID: 30838415
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of alkylating pyrrole-imidazole polyamide conjugates by a novel method for high-throughput sequencer.
Kashiwazaki G; Maeda R; Kawase T; Hashiya K; Bando T; Sugiyama H
Bioorg Med Chem; 2018 Jan; 26(1):1-7. PubMed ID: 29224995
[TBL] [Abstract][Full Text] [Related]
17. A novel gene regulator, pyrrole-imidazole polyamide targeting ABCA1 gene increases cholesterol efflux from macrophages and plasma HDL concentration.
Tsunemi A; Ueno T; Fukuda N; Watanabe T; Tahira K; Haketa A; Hatanaka Y; Tanaka S; Matsumoto T; Matsumoto Y; Nagase H; Soma M
J Mol Med (Berl); 2014 May; 92(5):509-21. PubMed ID: 24463557
[TBL] [Abstract][Full Text] [Related]
18. Fadd and Skp2 are possible downstream targets of RUNX1-EVI1.
Maki K; Sugita F; Nakamura Y; Sasaki K; Mitani K
Int J Hematol; 2013 Jan; 97(1):83-91. PubMed ID: 23250858
[TBL] [Abstract][Full Text] [Related]
19. Nuclear localization of pyrrole-imidazole polyamide-fluorescein conjugates in cell culture.
Best TP; Edelson BS; Nickols NG; Dervan PB
Proc Natl Acad Sci U S A; 2003 Oct; 100(21):12063-8. PubMed ID: 14519850
[TBL] [Abstract][Full Text] [Related]
20. MDS1/EVI1 enhances TGF-beta1 signaling and strengthens its growth-inhibitory effect but the leukemia-associated fusion protein AML1/MDS1/EVI1, product of the t(3;21), abrogates growth-inhibition in response to TGF-beta1.
Sood R; Talwar-Trikha A; Chakrabarti SR; Nucifora G
Leukemia; 1999 Mar; 13(3):348-57. PubMed ID: 10086725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
